Cargando…
Long-term temozolomide might be an optimal choice for patient with multifocal glioblastoma, especially with deep-seated structure involvement: a case report and literature review
BACKGROUND: Multifocal glioblastoma is an uncommon and refractory subtype of high-grade glioma since the burden of masses could not be eliminated simply by operation, and it is getting even harder to control if some deep structures, like thalamus and pineal region, are involved. CASE PRESENTATION: H...
Autores principales: | Liu, Yunpeng, Hao, Shuyu, Yu, Lanbing, Gao, Zhixian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393596/ https://www.ncbi.nlm.nih.gov/pubmed/25889578 http://dx.doi.org/10.1186/s12957-015-0558-x |
Ejemplares similares
-
Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma
por: Lou, Emil, et al.
Publicado: (2013) -
Take your seats: leftward asymmetry in classroom seating choice
por: Harms, Victoria L., et al.
Publicado: (2015) -
On optimal temozolomide scheduling for slowly growing glioblastomas
por: Segura-Collar, Berta, et al.
Publicado: (2022) -
Involvement of Intracellular Cholesterol in Temozolomide-Induced Glioblastoma Cell Death
por: YAMAMOTO, Yutaro, et al.
Publicado: (2018) -
Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)